HCPCS code E0748: Osteogenesis stimulator, spinal billing guide

Key Takeaways

HCPCS code E0748 identifies an electrical, non-invasive osteogenesis stimulator for spinal applications. DME suppliers bill it once per course of treatment.

The FDA reclassified E0748 from a Class III to a Class II device for dates of service on or after May 18, 2026. Suppliers no longer append the KF modifier, and claims that still include KF are rejected as incorrectly coded.

Medicare covers E0748 under LCD L33796 only when the ordering physician documents a qualifying spinal fusion indication before the device is dispensed. Billing before the criteria are met is the leading cause of denials.

Pabau’s claims management software helps DME suppliers and ordering clinicians track modifier changes, maintain documentation checklists, and reduce preventable E0748 denials.

HCPCS code E0748 is the Level II code for an osteogenesis stimulator, electrical, non-invasive, spinal applications. The device delivers pulsed electromagnetic field (PEMF) or combined magnetic field (CMF) therapy to stimulate spinal bone growth without surgery. DME suppliers bill it once per course of treatment.

One change dominates E0748 billing in 2026. For dates of service on or after May 18, the FDA reclassified the device from Class III to Class II, so the KF modifier no longer applies. Suppliers who submit through claims management software should update their modifier logic to avoid rejected DMEPOS claims.

HCPCS code E0748: Description and clinical context

HCPCS code E0748 is the Level II Healthcare Common Procedure Coding System code maintained by CMS for: Osteogenesis stimulator, electrical, non-invasive, spinal applications. This code covers devices that deliver pulsed electromagnetic fields (PEMF) or combined magnetic field (CMF) therapy to stimulate bone growth in the spine without surgical implantation.

E0748 applies to all anatomical levels of the spine. UnitedHealthcare’s provider policy confirms it covers bone growth stimulation at any spinal level. That makes it the single code for cervical, thoracic, and lumbar non-invasive electrical stimulation. Suppliers bill it once per course of treatment for the device rental or purchase, not per session.

E0748 falls under the Stimulation Devices category in the HCPCS Level II code set maintained by CMS. It has been active since 1996 and carries no planned retirement date as of the 2026 code year. Suppliers managing similar device codes may also reference the HCPCS code E2607 wheelchair cushion billing guide for parallel DMEPOS documentation patterns.

Medicare coverage criteria: LCD L33796

Local Coverage Determination L33796 (Osteogenesis Stimulators) governs Medicare coverage for E0748. Medicare covers a spinal electrical osteogenesis stimulator only when the patient meets at least one of these documented criteria before the device is dispensed:

• Failed spinal fusion: a spinal fusion has failed to heal and at least nine months have passed since the last surgery, with radiographic evidence of non-union or delayed union at the fusion site.
• Multilevel spinal fusion: the fusion involves three or more vertebrae (for example, L3–L5 or L4–S1).
• Prior failed fusion at the same site: the patient is undergoing spinal fusion at a site where an earlier fusion has already failed.

LCD L33796 requires suppliers to determine coverage at the time of the initial order, not retrospectively. A supplier who dispenses the device before verifying one of these criteria carries the full repayment risk in a post-pay review. The ordering physician’s records must substantiate the indication, not a supplier-generated form.

Non-covered indications

E0748 does not cover acute fracture healing at spinal sites, routine post-operative bone growth support without a qualifying LCD indication, or degenerative disc disease without fusion. Coding outside the covered indications is a leading audit trigger.

Coders should confirm that the ordering physician’s clinical notes address one of the three LCD criteria directly. A diagnosis code alone, without the supporting rationale, is not enough.

Modifier requirements: the 2026 KF change

The biggest 2026 change to E0748 billing concerns the KF modifier, which identifies an FDA Class III device. Through May 17, 2026, CMS Policy Article A52513 classified E0747, E0748, and E0760 as Class III devices, so every claim needed KF.

The FDA then reclassified these three codes as Class II devices, effective for dates of service on or after May 18, 2026. For those claims, suppliers do not append KF. Medicare rejects E0748 lines that still carry the KF modifier as incorrectly coded.

Suppliers reconciling older claims should keep the cutoff clear: KF was required before May 18, 2026, and is rejected on or after that date.

Getting the modifier right at order entry matters more than catching it at billing. Digital intake forms and structured intake workflows help suppliers record the correct modifier logic for the date of service, so the claim goes out clean the first time.

Practices that also handle HCPCS code L1843 knee orthosis billing apply similar modifier discipline across prefabricated DME categories.

EY modifier: When no physician order exists

Suppliers append the EY modifier when the device was provided without a valid physician order. It tells Medicare the claim does not meet the standard order requirement, which typically results in denial. Never dispense an E0748 device without a written order from the treating physician. Doing so creates both a coverage and a compliance problem.

Maintaining organized medical forms at your practice ensures order documentation is captured and retained before equipment is released. Clinicians ordering bone-growth devices alongside post-surgical protocols may also find the Achilles tendon rupture treatment guidelines handout a useful reference for musculoskeletal aftercare documentation.

2026 Medicare fee schedule and reimbursement rate

The 2026 Medicare non-facility rate for E0748 is approximately $3,437.99, effective January 1, 2026. The allowed amount adjusts by locality.

Expect this figure to change. CMS has said it will recalculate the fees for E0747, E0748, and E0760 in the July 2026 DMEPOS update to reflect the Class II reclassification. Verify the current rate against the official CMS fee schedule before you submit.

Commercial reimbursement varies widely. Independence Blue Cross (IBX) and other regional plans set their own medical policies for osteogenesis stimulators. Those policies may differ from Medicare LCD L33796 on coverage criteria and prior authorization. Check the individual payer policy before dispensing.

For providers managing multiple payers, structured patient scheduling and appointment management workflows can help ensure payer verification is completed before equipment is ordered.

E0748 vs E0747 vs E0760: Choosing the right code

Selecting the wrong code between E0748 and its close relatives is the most common coding error in this category. The distinction turns entirely on the site of application and device mechanism.

• E0748: Electrical, non-invasive, spinal applications. Use for cervical, thoracic, and lumbar fusion sites. This is the correct code regardless of which spinal level is being stimulated.
• E0747: Electrical, non-invasive, non-spinal (peripheral) applications. Use for long bone fracture non-union, failed non-spinal joint fusion, or congenital pseudarthrosis. Congenital pseudarthrosis qualifies under E0747, not E0748.
• E0760: Low intensity ultrasound, non-invasive. The mechanism is ultrasonic rather than electromagnetic. Used for both spinal and non-spinal applications when the device uses ultrasound technology.
• E0749: Electrical, surgically implanted. Reserved for internal spinal stimulators placed during surgery. Not a DME supplier code in the same billing context as E0748.

The practical test: if the device is non-invasive, electrical (PEMF or CMF technology), and applied to the spine, E0748 is the correct code. If the patient has a lumbar fusion and the device uses ultrasound, E0760 applies instead. Submitting E0748 when the clinical record indicates an ultrasound device is an unbundling and accuracy issue that payers audit actively.

For practices managing physical therapy documentation and DME ordering together, maintaining clear device-type fields in patient records prevents miscoding at the point of care. Related non-invasive device billing such as the HCPCS code E2510 speech generating device guide illustrates how device classification drives code selection across DME categories.

Reduce E0748 claim denials with cleaner documentation workflows

Pabau's claims management tools help DME suppliers and ordering clinicians track modifier requirements, maintain documentation checklists, and flag missing physician orders before submission.

Book a demo

Documentation requirements for E0748

CMS documentation requirements for E0748 are detailed in the CGS Medicare Osteogenesis Stimulators Documentation Checklist. Both the ordering physician’s record and the supplier’s file must be complete before billing. Missing documentation discovered in a post-pay audit triggers full repayment of the allowed amount.

Ordering physician records

The physician’s office file must contain all of the following for a clean E0748 claim:

• A written order specifying the HCPCS code, diagnosis, and treating clinician’s signature
• Clinical notes documenting the covered indication (failed fusion, high-risk fusion, or congenital pseudarthrosis) with specific reference to the LCD L33796 criterion being met
• Radiographic evidence supporting the diagnosis (imaging reports, operative notes from the original fusion procedure)
• Documentation of the qualifying basis being claimed: the nine-month failed-fusion timeline, the multilevel fusion (three or more vertebrae), or the prior failed fusion at the same site
• A face-to-face evaluation by the ordering physician documenting the clinical need for the device

Supplier file requirements

The DME supplier’s own file must separately retain:

• A copy of the signed physician order
• Evidence of PDAC product classification verification confirming the dispensed device appears on the current PDAC Product Classification List for E0748
• The beneficiary’s Medicare eligibility confirmation at the time of dispensing
• Delivery documentation (signed delivery receipt or equivalent)
• The KF modifier flag recorded at claim entry

Both the physician and supplier files must follow HIPAA-compliant documentation practices. Coders managing concurrent injection drug claims can also consult the HCPCS code A4211 supplies for self-administered injections guide for a related DME documentation parallel.

CMS requests records from both parties in an E0748 audit. Missing documentation in either file can trigger a denial, even when the clinical indication was legitimate.

Using structured capture forms for intake documentation helps ensure all required fields are collected at the time of order. Teams also billing for non-chemo oral medications alongside DME should reference the HCPCS code J8499 non-chemo oral drug billing guide for documentation parallels across unclassified categories.

PDAC product classification and verification

The Pricing, Data, Analysis and Coding (PDAC) Contractor, administered on behalf of CMS, maintains the Product Classification List for DMEPOS items including E0748. Suppliers must confirm that the specific brand and model of device they are dispensing has been classified by PDAC under E0748 before billing Medicare.

Suppliers cannot bill a device under E0748 unless it appears on the PDAC Product Classification List, regardless of the clinical indication. A PDAC advisory article once covered E0747, E0748, and E0760. That advisory has been retired, but CMS still requires PDAC verification as a condition of coverage.

Check the current PDAC Product Classification List at dmepdac.com before stocking any new device model.

Products already assigned and published on the PDAC Product Classification List for E0748 do not require re-verification unless the device model changes. Suppliers who switch device vendors or introduce a new manufacturer’s product mid-contract should treat that as a new PDAC verification requirement.

Building this check into practice inventory management workflows keeps suppliers from stocking non-classified devices by mistake. Suppliers who also dispense injectable or infusible products may reference the HCPCS code J1642 heparin sodium lock flush billing guide for a contrast between per-unit and per-course billing.

Prior authorization and commercial payer requirements

Traditional Medicare fee-for-service does not require prior authorization for E0748. CMS suspended a prior-authorization requirement for these codes on August 28, 2024. Medicare Advantage plans and commercial payers, however, often impose their own prior-authorization rules that go beyond the Medicare LCD criteria.

Commercial payers and Medicare Advantage

Priority Health, for example, publishes a billing policy for osteogenesis stimulators that requires prior authorization. It also requires the anatomical site in the clinical documentation to match the HCPCS code billed. Independence Blue Cross (IBX) maintains a separate policy that covers E0748 as medically necessary under defined conditions.

Suppliers billing commercial plans should check each payer’s current policy, since payers update these independently of Medicare LCDs. Some commercial payers also require ongoing use documentation before they approve continued coverage, so track patient compliance with the prescribed protocol.

Providers who want to grow the patient base for these devices can review 7 strategies that fill schedules for referral and outreach approaches.

Payer-specific notes and crosswalk references help suppliers spot which commercial plans set their own E0748 policies before they submit a claim. Practice management software that logs authorization numbers and expiration dates reduces the risk of billing after an authorization lapses.

Practices that also handle principal care management can review the CPT code 99424 principal care management billing guide to see how authorization interacts with ongoing chronic-condition coding.

Post-pay review risk and denial prevention

CMS announced a widespread post-pay, service-specific review of HCPCS codes E0747, E0748, and E0760 in April 2021. High error rates in documentation and modifier compliance across the osteogenesis stimulator category triggered it.

The review put flagged claims through full medical review. Suppliers with high denial rates faced extrapolation, where CMS applies a sample denial rate to a broader universe of claims.

The most common denial reasons in E0748 post-pay reviews fall into four categories:

• Incorrect modifier use: for dates of service on or after May 18, 2026, appending the retired KF modifier now causes rejection. Match the modifier to the date of service.
• No documented LCD criterion: Physician notes reference the diagnosis but do not explicitly address which of the three LCD L33796 criteria applies.
• Device not on PDAC list: The dispensed device model has not been classified under E0748 by the PDAC contractor.
• No valid written order: The order was verbal, unsigned, or dated after the device was dispensed.

Suppliers can address all four with a pre-dispensing checklist that is completed and signed before any E0748 device leaves the warehouse. Building that checklist into your documentation workflow ensures it becomes a required step in the order process rather than an afterthought.

Conclusion

Three requirements drive clean E0748 claims. First, match the modifier to the date of service: for dates of service on or after May 18, 2026, omit KF, because the device is now Class II. Second, document an LCD L33796 spinal indication in the ordering physician’s records before the device ships. Third, confirm the dispensed product appears on the current PDAC Product Classification List.

Meeting those three requirements consistently eliminates the vast majority of E0748 denials.

Pabau’s claims management software helps DME suppliers and ordering clinicians build these checks into their pre-submission workflow, flagging missing modifiers and incomplete documentation before claims reach the payer. To see how Pabau handles DMEPOS billing workflows, book a demo.

Continue your research

Need a structured approach to DME inventory control? Automating clinic inventory management outlines how automated tracking prevents stocking and billing errors on DMEPOS items.

Billing across specialties that order DME? Specialty procedure code documentation requirements explains the documentation standards that apply when ordering physicians span multiple practice types.

Frequently asked questions